Shopping Cart
- Remove All
- Your shopping cart is currently empty
Antileishmanial agent-17, a coumarin hybrid, exhibits potent antileishmanial activity (IC50 <0.78 μM) while proving non-toxic to normal VERO cells. It specifically interacts with the folate pathway enzymes pteridine reductase and DHFR-TS. Efficacy against the promastigote form is highlighted by an IC50 value of 0.40 μM, and against the amastigote form, an IC50 of 0.68 μM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 8-10 weeks | |
50 mg | $1,980 | 8-10 weeks | |
100 mg | $2,500 | 8-10 weeks |
Description | Antileishmanial agent-17, a coumarin hybrid, exhibits potent antileishmanial activity (IC50 <0.78 μM) while proving non-toxic to normal VERO cells. It specifically interacts with the folate pathway enzymes pteridine reductase and DHFR-TS. Efficacy against the promastigote form is highlighted by an IC50 value of 0.40 μM, and against the amastigote form, an IC50 of 0.68 μM, respectively. |
In vitro | Antileishmanial agent-17 (compound 14b) inhibits the folate pathway, demonstrating inhibition rates of 82% and 91% for folates, and 88% and 91% for dihydrofolates at concentrations of 20 μM and 100 μM, respectively [1]. It exhibits low cytotoxicity against African green monkey kidney cells (VERO cells), with a CC50 of 244.3 μM [1]. |
Molecular Weight | 511.61 |
Formula | C27H37N5O5 |
Cas No. | 2934738-40-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.